Hall |
08:00-14:30 | Attendees registration |
Council meeting Etxepare room |
08:30-10:00 | Regional society council meeting PASPCR |
Council meeting Elhuyar room |
08:30-10:00 | Regional society council meeting JSPCR |
Council meeting Baroja room |
08:30-10:00 | Regional society council meeting ESPCR |
Council meeting Arriaga room |
08:30-10:00 | Regional society council meeting ASPCR |
Chillida and Axular rooms |
10:00-10:30 | Coffee break |
Council meeting Arriaga room |
10:30-11:30 | Council meeting IFPCS |
Institutional welcome - Opening session Mitxelena room |
11:30-11:35 |
Welcome
1
Chair of the IPCC 2023, University of the Basque Country (UPV/EHU), Bilbao, Spain |
11:35-11:40 |
Speech
1
Director of Scientific and Social Development, UPV/EHU, Bilbao, Spain |
11:40-11:45 |
Speech
1
Councillor for the Mayor's Office and Culture, Bilbao City Council, Bilbao, Spain |
11:45-11:55 | Handover of the IPCC2020 torch to IPCC2023 by Prof. Tamio Suzuki |
11:55-12:05 |
Speech
1
Nippon Medical School · Department of Dermatology, Tokyo, Japan |
12:05-12:15 | Kresala dantza taldea |
12:20-12:30 |
Welcome and presentation of the opening lecture by Dr. Greg BARSH
1
National Center For Biotechnology (CNB-CSIC) and CIBER of Rare Diseases (CIBERER - ISCIII), Madrid, Spain |
12:30-13:00 |
Genetics and genomics of mammalian color patterns
1
HudsonAlpha Institute and Stanford University, Standford, United States of America |
Chillida and Axular rooms |
13:00-14:30 | Welcome reception |
Plenary 1 - Opening session
Mitxelena room Chairpersons: Yoko FUNASAKA, Nippon Medical School · Department of Dermatology, Japan Lluis MONTOLIU, National Center For Biotechnology (CNB-CSIC) and CIBER of Rare Diseases (CIBERER - ISCIII), Spain |
14:30-15:00 |
Light and pigment cell
1
Nippon Medical School · Department of Dermatology, Tokyo, Japan |
15:00-15:20 |
2023 ESPCR HS Raper Medal Tracking the melanogenic pathway to unravel the functional role of melanins: the bottom-up approach 1
University of Naples Federico II, Naples, Italy |
15:20-15:40 |
2023 IFPCS Myron Gordon Award Painting the neural crest: how studying pigment cells illuminates neural crest cell biology 1
University Of Bath, Bath, United Kingdom |
15:40-15:45 |
2023 IFPCS Seiji Memorial Lecture Will be delivered in Plenary 6 |
15:45-16:05 |
2023 JSPCR Takeuchi Medal Genetic compensation for Kit loss of function mutation engaged possibly by the global gene expression change. 1
Department of Tissue and Organ Development, Gifu, Japan |
16:05-16:25 |
2023 PASPCR Aaron Lerner Award Mouse models of melanoma 1
Massachusetts General Hospital, Boston, Massachusetts, United States of America |
16:25-16:45 |
2023 PCMR Thomas B. Fitzpatrik Medal Role of autophagy in skin pigmentation 1
Yonsei University College Of Medicine, Seoul, Republic of Korea |
Chillida and Axular rooms |
16:45-17:15 | Coffee break |
Plenary 2 - Pigmentation genetics
Mitxelena room Chairpersons: Tamio SUZUKI, Department Of Dermatology, Faculty Of Medicine, Yamagata University, Japan Stacie LOFTUS, Staff Scientist at National Human Genome Research Institute, United States of America |
17:15-17:45 |
The genetics of oculocutaneous albinism and chemical-induced vitiligo
1
Department Of Dermatology, Faculty Of Medicine, Yamagata University, Yamagata, Japan |
17:45-18:15 |
Lessons learned from finding missing genetic heritability in oculocutaneous albinism
1
Staff Scientist at National Human Genome Research Institute, Washington DC, United States of America |
18:10-18:40 |
Modulating TGFβ signaling output in neural crest stem cells and melanoma
1
University of Zurich, Zurich, Switzerland |
18:45-19:00 |
Cyclical Fate Restriction in the zebrafish neural crest: Ltk signalling promotes iridophore fate determination by repressing melanophore and xanthophore fates.
1
University of Bath, Bath, United Kingdom |
19:00-19:15 |
The complexity of simple genetics: oligogenic patterns in albinism
1
University of Manchester & Manchester Centre for Genomic Medicine, Manchester, United Kingdom |
19:15-19:30 |
An induced suppressor mutation in mouse MITF unravels the functional role of the carboxyl-end of MITF and provides important information on the melanoma-predisposing E318K mutation in humans.
1
Department of Biochemistry and Molecular Biology, BioMedical Center, Faculty of Medicine, University of Iceland, 102 Reykjavík, Iceland |
Hall |
08:00-13:15 | Reception open |
Plenary 3 - Melanoma 1
Mitxelena room Chairpersons: Chikako NISHIGORI, Kobe University, Japan Susana PUIG, Hospital Clínic De Barcelona, Dermatology Department, Spain |
08:15-08:45 |
New insights in deep phenotyping and genetics of melanoma
1
Hospital Clínic De Barcelona, Dermatology Department, Barcelona, Spain |
08:45-09:15 |
Plasticity in melanoma
1
FAU Erlangen-Nürnberg, Erlangen, FAU Erlangen-Nürnberg, Germany |
08:45-09:15 |
Seeds for new therapeutic strategies of malignant melanoma
1
Div. Dermatology, Dep. Internal Related, Kobe University Graduate School of Medicine, Kobe, Japan |
09:45-10:00 |
Heterozygous bap1 knockout accelerates uveal melanoma progression
1
Life Sciences Institute, University of British Columbia, Vancouver, Canada |
10:00-10:15 |
CTLA4 mRNA Is Downregulated by miR-155 in Regulatory T Cells, and Reduced Blood CTLA4 Levels Are Associated With Poor Prognosis in Metastatic Melanoma Patients
1
Department of Dermatology, University of Colorado Anschutz Medical Campus, Colorado, United States of America |
10:15-10:30 |
Targeting metabolic adaptation to breakdown resistance to targeted therapy in metastatic melanoma
1
Institut Gustave Roussy, Villejuif, France |
Chillida and Axular rooms |
10:30-11:00 | Coffee break |
Plenary 4 - Melanoma 2
Mitxelena room Chairpersons: Dr Robert BALLOTTI, Inserm U1065, France Ze'ev RONAI, Sanford Burnham Prebys Medical Discovery Institute, United States of America |
11:00-11:30 |
Coordinated control of melanoma cell proliferation, metastatic potential and immune suppression by the dsRNA helicase DDX46
1
CNIO, Madrid, Spain |
11:30-12:00 |
Melanoma Control by the TME
1
Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States of America |
12:00-12:30 |
Understanding the molecular mechanisms involved in uveal melanoma progression reveal new actionable vulnerabilities
1
Université Côte D’Azur, Niza, France |
12:30-12:45 |
The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma
1
Institut Curie, PSL Research University, INSERM U1021, CNRS UMR 3347, Orsay, France |
12:45-13:00 |
POMT1 and dystroglycan glycosylation in melanoma progression.
1
Florida International University, Miami, United States of America |
13:00-13:15 |
Small extracellular vesicle-based human melanocyte and melanoma signature
1
Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Bilbao, Spain |
Chillida and Axular rooms |
13:15-14:15 | Lunch |
Poster sessions Oteiza room |
14:15-15:15 |
Poster sessions, P0-01 to PO-35 Topics: Animal models, Melanins and melanosomes, Melanoma I and II, Melanoma therapies and Pigmentation genetics. All posters will remain in exhibition during the entire meeting. See below. |
Concurrent 1 - Animal models
Mitxelena room Chairpersons: Berta SANCHEZ-LAORDEN, Institute of Neurosciences CSIC-UMH, Spain Elizabeth PATTON, University of Edinburgh, United Kingdom |
15:15-15:45 |
Targeting developmental lineages in melanoma
1
University of Edinburgh, Edinburgh, United Kingdom |
15:45-16:15 |
Microenvironmental regulation of melanoma progression
1
Institute of Neurosciences CSIC-UMH, San Juan de Alicante, Spain |
16:15-16:30 |
Revealing the intricacies of iridosome-mediated guanine crystal formation in zebrafish iridophores: insights into acidic microenvironment, organelle maturation, and RNA signatures
1
Weizmann Institute of Science, Molecular Genetics Department, Rehovot, Israel |
16:30-16:45 |
Disrupting the seed and soil crosstalk: altering the metastatic niche in melanoma to impede tumor growth
1
Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, Leioa, Spain, Leioa, Spain |
Concurrent 2 - Vitiligo
Baroja room Chairpersons: Davinder PARSAD, Institute of Medical Education and Research (PGIMER), India Caroline LE POOLE, Northwestern University Feinberg School of Medicine, United States of America |
15:15-15:45 |
Vitiligo treatment: Current and emerging directed therapies
1
Institute of Medical Education and Research (PGIMER), Chandigarh, India |
15:45-16:15 |
Dietary components align with disease activity in human vitiligo
1
Northwestern University Feinberg School of Medicine, Chicago, United States of America |
16:15-16:30 |
Impact of House-Dust-Mite in Vitiligo Skin: Environmental Contribution to Increased Cutaneous Immunity and Melanocyte Detachment
1
Université Côte d’Azur, INSERM U1065,Centre Méditerranéen de Médecine Moléculaire, Nice, France |
16:30-16:45 |
Dysregulated USP18-ISG15 network promotes IFN-α secretion from CD8+ T cells via LFA-1 in vitiligo
1
Department of Dermatology, Yonsei University College of Medicine & Cutaneous Biology Research Institute, Seoul, Republic of Korea |
Chillida and Axular rooms |
16:45-17:15 | Coffee break |
Concurrent 3 - Advances in Melanoma Therapies: new targets, molecular mechanisms and clinical translation
Mitxelena room Chairpersons: Alfonso BERROCAL, Medical Oncology Service, Consortium General University Hospital of Valencia and GEM, Spain Svenja MEIERJOHANN, University of Würzburg, Institute of Pathology, Germany |
17:15-17:45 |
Metabolic rewiring as a target in cutaneous melanoma
1
NAVARRABIOMED-FMS-IDISNA, Pamplona, Spain |
17:45-18:15 |
Stress adaptation in melanoma: the role of NRF2
1
University of Würzburg, Institute of Pathology, Würzburg, Germany |
18:15-18:30 |
Identification of circRNAs involved in acquisition of BRAFi resistance in metastatic melanoma
1
Institut de Génétique et Développement de Rennes, Rennes, France |
18:30-18:45 |
Ferroptosis as a therapeutic opportunity to counteract BRAFi-resistance in melanoma
1
IGDR UMR6290 CNRS, Rennes, France |
Concurrent 4 - Melanins
Baroja room Chairpersons: Michal SARNA, Jagiellonian University, Poland Kazumasa WAKAMATSU, Fujita Health University, Japan |
17:15-17:35 |
Analysis of melanin pigmentation in human melanoma cells with different metastatic potential
1
Jagiellonian University, Krakow, Poland |
17:35-17:55 |
A Chemist’s View of Melanogenesis: Update
1
Fujita Health University, Toyoake, Japan |
17:55-18:15 |
Role of vitamin D signaling in pigment cell biology
1
University of Alabama at Birmingham, Birmingham, United States of America |
18:15-18:30 |
DHI eumelanin content revealed in human skin with varying degrees of constitutive pigmentation
1
L’Oreal Research and Innovation, Aulnay-sous-Bois, France, France |
18:30-18:45 |
Ethanol and its metabolite, acetaldehyde, induces melanocyte activation and unique DNA damage in melanocytes
1
Department of Dermatology, University of Colorado Anschutz Medical Campus, Colorado, United States of America |
Public outreach event Arriaga room |
19:00- |
IPCC Dialogues This is a public outreach event, in Spanish and Basque language only |
Hall |
08:00-13:15 | Reception open |
Plenary 5 - Biology of pigment organelles
Mitxelena room Chairpersons: Graça RAPOSO, Institut Curie · Department of Cell Biology, France Duarte BARRAL, NOVA Medical School, Portugal |
08:15-08:45 |
Mechanisms of melanosome biogenesis revealed by rare genetic disease
1
The Children's Hospital of Philadelphia, Philadelphia, United States of America |
08:45-09:15 |
Shedding light on the mechanisms of melanin transfer and processing
1
NOVA Medical School, Lisboa, Portugal |
09:15-09:45 |
Cell biology of pigmented keratinocytes: from pigment position to DNA photoprotection
1
Institut Curie, Paris, France |
09:45-10:00 |
Unraveling the molecular mechanisms underlying intracellular crystal formation
1
Weizmann Institute of Science, Molecular Genetics Department, Rehovot, Israel |
10:00-10:15 |
3D ultrastructure analysis reveals the presence of abnormal macromelanosomes in keratinocytes of actinic lentigines
1
L'Oréal Research and Innovation, Aulnay-sous-Bois, France |
10:15-10:30 |
Differential uptake of exosomes by stressed and healthy melanocytes and its effect on melanogenesis.
1
Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India |
Chillida and Axular rooms |
10:30-11:00 | Coffee break |
Plenary 6 - Melanocyte development
Mitxelena room Chairpersons: Lionel LARUE, Institut Curie, France Takahiro KUNISADA, Department of Tissue and Organ Development, Japan |
11:00-11:15 |
2023 IFPCS Seiji Memorial Lecture Distinct Functional Heterogeneity of Melanocyte Stem Cells 1
University of Maryland, School of Medicine, Baltimore, United States of America |
11:15-11:40 |
α-catenin during the establishment of the melanocyte lineage
1
Institut Curie, Orsay, France |
11:40-12:05 |
MITF represses neural genes to specify melanocytes
1
Kyoto University Graduate School of Medicine, Kyoto, Japan |
12:05-12:30 |
Analysis of Integrin-Dependent Cell-ECM adhesion in Melanoblast Migration During Development
1
University of British Columbia, Vancouver, Canada |
12:30-12:45 |
Sex differences in melanocyte stem cell behavior reveals therapeutic strategies for re-pigmentation
1
Cornell University, Ithaca, NY, United States of America |
12:45-13:00 |
The developmental origin of aortic valve melanocytes
1
Florida International University, Miami, United States of America |
13:00-13:15 |
Uncovering Core Cell Lineages that Generate Melanoma Tumors
1
University of California, Irvine, Irvine, United States of America |
Chillida and Axular rooms |
13:15-14:15 | Lunch |
Poster sessions Chillida room |
14:15-15:15 |
Poster sessions, PO-37 to PO-53 Topics: Melanocyte development, Molecular mechanisms of other pigmentary disorders, Signal transduction and Melanocyte environment. All posters will remain in exhibition during the entire meeting. See below. |
Concurrent 5 - Signal transduction
Mitxelena room Chairpersons: Celia JIMÉNEZ-CERVANTES, University of Murcia, Spain Jonathan ZIPPIN, Englander Institute for Precision Medicine, United States of America |
15:15-15:45 |
Regulation of melanosomal pH and pigmentation by distinct cAMP micro domains
1
Englander Institute for Precision Medicine, New York, United States of America |
15:45-16:15 |
Regulation of the Hair Follicle Stem Cell Niche Fate during Skin Pigmentation
1
A*star, Singapore, Singapore |
16:15-16:30 |
Loss of MC1R signaling implicates TBX3 in pheomelanogenesis and melanoma predisposition
1
National Human Genome Research Institute, National Institutes of Health, Bethesda, United States of America |
16:30-16:45 |
Unique Tetrapeptide α-MSH Analogs Rescue Human Melanocytes from Solar UV-Induced Oxidative Stress
1
University of Cincinnati, Cincinnati, United States of America |
Concurrent 6 - Albinism
Baroja room Chairpersons: Lluis MONTOLIU, National Center For Biotechnology (CNB-CSIC) and CIBER of Rare Diseases (CIBERER - ISCIII), Spain Sophie JAVERZAT, INSERM U1211 MRGM, France |
15:15-15:40 |
Albinism: where do we stand?
1
Université de Bordeaux, Bordeaux, France |
15:40-16:05 |
Albinism: what have we learnt from animal models?
1
National Center For Biotechnology (CNB-CSIC) and CIBER of Rare Diseases (CIBERER - ISCIII), Madrid, Spain |
16:05-16:30 |
L-Dopa, the usual suspect in OCA retinal anomalies
1
INSERM U1211 MRGM, BORDEAUX, France |
16:30-16:45 |
Ultrastructure study of melanosomes from retinal pigment epithelium of OCA1A and OCA2 forms of Albinism
1
National Institutes of Health, Bethesda, United States of America |
Chillida and Axular rooms |
16:45-17:15 | Coffee break |
Concurrent 7 - Molecular mechanisms of other pigmentary disorders
Mitxelena room Chairpersons: Leah VARDY, A*STAR, Singapore Heather ETCHEVERS, INSERM, Aix-Marseille Université, France |
17:15-17:45 |
Polyamines: Novel Regulators Of Human Epidermal Pigmentation
1
A*STAR, Singapore, Singapore |
17:45-18:15 |
Cellular diversity in large/giant congenital melanocytic nevi
1
INSERM, Aix-Marseille Université, Marseille, France |
18:15-18:30 |
Possible mechanism of tranexamic acid in the treatment of refractory melasma and Riehl’s melanosis: regulating the expression of CCN1 by inhibiting plasmin
1
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China |
18:30-18:45 |
Melanoma in patients with xeroderma pigmentosum (XP): lessons from Japanese nationwide survey for XP and clinical practice on melanoma in XP patients
1
Kobe University, Kobe, Japan |
Concurrent 8 - Melanocyte environment
Baroja room Chairpersons: Dr. José Carlos GARCÍA-BORRÓN, University of Murcia, Spain Emi K. NISHIMURA, The Institute Of Medical Science, The University Of Tokyo, Japan |
17:15-17:40 |
Functions of Extracellular Vesicles in pigmentation and intercellular communication in the skin
1
Institut Curie · Department of Cell Biology, Paris, France |
17:40-18:05 |
Environmental regulation of melanocyte stem cell dynamics, fate and melanomagenesis
1
The Institute Of Medical Science, The University Of Tokyo, Tokyo, Japan |
18:05-18:20 |
Analysis of apoptosis susceptibility in distinct human cutaneous melanocyte subpopulations and in melanoma cells of different subtypes and melanin status
1
Charles Institute of Dermatology, University College Dublin, Dublin, Ireland |
18:20-18:35 |
Melanosomes as new cancer immune modulators of melanoma
1
Tel Aviv University - School of Medicine, Tel Aviv, Israel |
18:35-18:50 |
Lysosome specialization during keratinocyte differentiation: enlightening future views of skin homeostasis
1
Indian Institute of Science, Bengaluru, India |
Hall |
08:00-13:15 | Reception open |
Plenary 7 - UVR and the skin
Mitxelena room Chairpersons: Boon Kee GOH, Skin Physician At Mount Elizabeth Medical Centre, Singapore Marie Dominique GALIBERT, Université De Rennes, France |
08:15-08:45 |
Understanding How UV-exposure Shapes Melanoma Biology
1
Université De Rennes, Rennes, France |
08:45-09:15 |
Impact of UVB photon density on photocarcinogenesis of the skin
1
Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China |
09:15-09:35 |
Benefit of an enlarged photoprotection in the UVA1 wavelengths range for preventing skin photodamage and hyperpigmentation.
1
L'Oréal Research and Innovation, Aulnay-sous-Bois, France |
09:35-09:55 |
The duality of melanin: opposing roles of cell-intrinsic pigment in melanoma formation
1
The Ohio State University, Columbus, United States of America |
09:55-10:15 |
The role of melanocytes´ senescence in the process of UV-induced skin aging
1
University of Innsbruck – Department for Biomedical Aging Research, Innsbruck, Austria |
Chillida and Axular rooms |
10:15-11:00 | Coffee break |
Plenary 8 - Pigmentary disorders
Mitxelena room Chairpersons: Flora XIANG, Huashan Hospital, Fudan University, People's Republic of China Mauro PICARDO, Unicamillus International University, Italy |
11:00-11:30 |
Photobiomodulation therapy for prevention or treatment of PIH and melasma: mechanism and clinical practice
1
Huashan Hospital, Fudan University, Shangai, People's Republic of China |
11:30-12:00 |
Oxidative stress in Vitiligo: a critical review
1
Unicamillus International University, Roma, Italy |
12:00-12:15 |
Role of CLEC12B in skin immunity
1
Centre Méditerranéen de Médecine Moléculaire (C3M), INSERM U1065, Nice, France |
12:15-12:30 |
Unraveling Griscelli’s syndrome hypopigmentation using an in vitro model
1
iNOVA4Health, CEDOC, NOVA Medical School, NMS, Universidade NOVA de Lisboa, Lisbon, Portugal |
12:30-12:45 |
Defining the inhibitory effects of secreted frizzled related protein 1 on melanocytes
1
KOSÉ Corporation Research Laboratories, Tokyo, Japan |
12:45-13:00 |
Melanin retention in keratinocytes could contribute to inflammatory environment observed in actinic lentigines
1
L'Oréal Research and Innovation, Aulnay-sous-Bois, France |
Chillida and Axular rooms |
13:15-14:15 | Lunch |
Etxepare room |
14:15-15:15 | General assembly PASPCR |
Elhuyar room |
14:15-15:15 | General assembly JSPCR |
Baroja room |
14:15-15:15 | General assembly ESPCR |
Poster sessions Axular room |
14:15-15:15 |
Poster sessions, PO-54 to PO-67 Topics: Innovative technologies, Pigmentary disorders, UVR and the skin and Clinical Treatment of pigmentary diserders. All posters will remain in exhibition during the entire meeting. See below. |
Arriaga room |
14:15-15:15 | General assembly ASPCR |
Concurrent 9 - Innovative technologies
Mitxelena room Chairpersons: Dr. Santos ALONSO, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Spain Muriel CARIO-ANDRÉ, Bordeaux University, France |
15:15-15:45 |
Geniouskin: the first pigmented artificial skin for clinical use
1
Bordeaux University, Bordeaux, France |
15:45-16:15 |
Spatial Lipidomics of melanoma
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
16:15-16:30 |
Discovery of 2-mercaptonicotinoyl glycine, a new potent lightening agent exhibiting a unique mode of action investigated in vitro and in vivo
1
L’Oréal Research and Innovation, Aulnay, France, Aulnay sous bois, France |
16:30-16:45 |
Magnetic nanodisks in melanocytes and melanoma cell cultures for cancer treatment
1
Department of Physical Chemistry, University of the Basque Country UPV/EHU, Leioa, Spain |
Concurrent 10 - Clinical treatment of pigmentary disorders
Baroja room Chairpersons: Rosa IZU, Dermatology department of the Basurto University Hospital, Spain Chengfeng ZHANG, Huashan Hospital, Fudan University, People's Republic of China |
15:15-15:30 |
The therapeutic effects of dermal rejuvernation in melasma using non-Invasive radiofrequency device
1
Department of Dermatology, Eulji Medical Center at Uijeongbu, Eulji University, Uijeongbu, Gyeonggido, Republic of Korea |
15:30-15:50 |
585-590 nm Light-emitting diodes (LEDs): A rising star for melasma treatment
1
Huashan Hospital, Fudan University, Shanghai, People's Republic of China |
15:50-16:10 |
The Challenges in Treating Melasma
1
Skin Physician At Mount Elizabeth Medical Centre, Singapore, Singapore |
16:10-16:25 |
Targeting the Elevated IFN-α in Vitiligo Patients by Human Anti- IFN-α Monoclonal Antibody Hampers Direct Cytototoxicity in Melanocyte
1
Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan City 333, Taiwan, Province of China |
Chillida and Axular rooms |
16:45-17:15 | Coffee break |
Council meeting 2 Arriaga room |
16:45-17:15 | Council meeting 2 IFPCS |
General assembly Mitxelena room |
17:15-17:45 | IFPCS |
Closure
Mitxelena room Chairperson: Dr. José Carlos GARCÍA-BORRÓN, University of Murcia, Spain |
17:45-18:15 |
Closure Journey through the Spectacular Landscapes of Melanocortin 1 Receptor 1
University Of Cincinnati College Of Medicine, Cincinnati, United States of America |
18:15-18:30 |
IPCC 2023 Farewell. Handing over the torch to Davinder Parsad on behalf of ASPCR, organizers of the next IPCC2026 in New Delhi, India. |
Poster sessions Oteiza room |
PO-01 |
Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
1
University of British Columbia, Vancouver, Canada |
PO-02 |
Role of Schwann cells in melanoma progression
1
Institute of Neurosciences CSIC-UMH, San Juan de Alicante, Spain |
PO-03 |
An oligodendrocyte progenitor cell-like population emerges in melanoma brain metastasis
1
Institute of Neurosciences CSIC-UMH, San Juan de Alicante, Spain |
PO-04 |
MGRN1 AS A PHENOTYPIC DETERMINANT OF HUMAN MELANOMA CELLS AND A POTENTIAL BIOMARKER
1
University of Murcia, Murcia, Spain |
PO-05 |
Androgen receptor in melanoma
1
University of Tennessee, Germantown, United States of America |
PO-06 |
A new AI tool to improve melanoma diagnosis and prognosis in early-stage melanoma patients
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
PO-07 |
SOX21 - Transcriptional Regulation in Malignant Melanoma
1
Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany |
PO-08 |
Copy number variations and fusion genes in driver mutation-negative melanoma
1
Sapporo Medical University, Sapporo, Japan |
PO-09 |
Tumor cell-derived sphingosine 1-phosphate promotes loss of adhesion to keratinocytes and contributes to primary melanoma invasion
1
Cancer Research Center of Toulouse, Toulouse Cedex 3, France |
PO-10 |
Transcriptional co-activators YAP1 and TAZ are drivers of vasculogenic mimicry in melanoma.
1
Boston University, Boston, United States of America |
PO-11 |
MICAL2, upregulated by α-catenin, induces invasion in melanoma
1
Institut Curie, Orsay, France |
PO-12 |
Enhanced intercellular adhesion by induction of E-cadherin and inhibition of Cdc42-GTPase in MGRN1-silenced human melanoma cells
1
University of Murcia, Murcia, Spain |
PO-13 |
Investigating the role of primary cilia and the ciliome in melanoma phenotype switching
1
Lancaster University, Lancaster, United Kingdom |
PO-14 |
Lysosomal function and intracellular position determine the malignant phenotype in melanoma
1
Department of Biomedical and Clinical Sciences (BKV), Linköping, Sweden |
PO-15 |
Targeting novel biomarkers in melanoma by proteomic and network biology analysis of the surfaceome
1
University of Debrecen, Department of Anatomy, Histology and Embryology, Debrecen, Hungary |
PO-16 |
The impact of UV radiation on proliferation, migration, and invasion in malignant melanoma
1
Linköping University, Linköping, Sweden |
PO-17 |
Unraveling the molecular mechanism underlying uric acid crystal formation in medaka leucophore cells
1
Weizmann Institute of Science, Rehovot, Israel |
PO-18 |
Depletion of tumor-reactive astrocytes diminishes melanoma growth in the brain
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
PO-19 |
Hepatic stellate cells favor melanoma metastasis through tumor microenvironment modulation
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
PO-20 |
A Spontaneous Melanoma Mouse Model Applicable For A Longitudinal Chemotherapy And Immunotherapy Study
1
Rutgers University, Piscataway, United States of America |
PO-21 |
Revealing the intricacies of iridosome-mediated guanine crystal formation in zebrafish iridophores: insights into acidic microenvironment, organelle maturation, and RNA signatures
1
Weizmann Institute of Science, Molecular Genetics Department, Rehovot, Israel |
PO-22 |
Identification and Validation of Autophagy-Related Genes in Vitiligo
1
Department Of Dermatology, Huashan Hospital, Fudan University, Shanghai, People's Republic of China |
PO-23 |
Biomarkers for early detection of repigmentation in non-segmental vitiligo patients after standard of care treatment.
1
Amsterdam Univerisity Medical Center, Amsterdam, Netherlands |
PO-24 |
Effects of marginal melanocyte infection by varicella-zoster virus (VZV) on the spread of segmental vitiligo lesions: An ultrastructural and anatomo-clinical study
1
Mohammed V University, Rabat, Morocco |
PO-26 |
Twenty years of Vitiligo: the experience of an Italian tertiary centre
1
University of Florence, firenze, Italy |
PO-27 |
Role of CXCR3 and its primary ligands in inducing melanocyte apoptosis in segmental and non-segmental vitiligo pathogenesis.
1
Post Graduate Institute of Medical Education and Research, Chandigarh, India |
PO-28 |
Clinical Importance of Autoantibodies to Sox 10 and Lamin A/C as Prognostic Factors in Sera from Vitiligo Patients
1
Dong-A University Hospital, Busan, Republic of Korea |
PO-29 |
The risk of non-melanoma skin cancer in vitiligo patients: a systematic review and meta-analysis on the association, and the potential mechanisms involved.
1
Amsterdam University Medical Center, Amsterdam, Netherlands |
PO-30 |
The expression and function of JAK3 and TEC family kinases in the pathogenesis of vitiligo.
1
Amsterdam Univerisity Medical Center, Amsterdam, Netherlands |
PO-31 |
Improvement of vitiligo metabolic state
1
San Gallicano Dermatological Institute, IRCCS, Roma, Italy |
PO-32 |
Analyzing resistance of AXL- and/or MITF-expressing melanoma cells to immunotherapy
1
Amsterdam Univerisity Medical Center, Amsterdam, Netherlands |
PO-33 |
ATP1A1 is a new promising target for melanoma treatment that can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
1
Institut Jules Bordet, Brussels, Belgium |
PO-34 |
Inhibition of melanoma tumor growth by PHBs targeting
1
Free University of Brussels, Brussels, Belgium |
PO-35 |
A negative charge and a carboxyl terminus are necessary for the phosphatidylserine-induced phagocytosis of extracellular melanosome clusters by dermal fibroblasts
1
Okayama University of Science, Okayama, Japan |
Poster sessions Chillida room |
PO-37 |
Melanin pigments internalization by keratinocytes
1
Institut Curie, Paris, France |
PO-38 |
Rabβa regulates melanin exocytosis and transfer induced by keratinocyte-conditioned medium
1
NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal |
PO-39 |
A multicistronic allele of Pmel yielding highly specific CreERT2 mediated recombination in melanoblasts and melanocytes
1
Lancaster University, Lancaster, United Kingdom |
PO-40 |
Exploring the Formation of Highly Reflective Guanine Crystals in Iridophore Cells
1
Ben Gurion University of the Negev, Beer Sheva, Israel |
PO-41 |
MAHOGUNIN RING FINGER 1 IS INVOLVED IN THE REPLICATIVE STRESS RESPONSE IN MELANOCYTIC CELLS
1
University of Murcia, Murcia, Spain |
PO-42 |
A VIS-À-VIS COMPARISON OF WILDTYPE AND VARIANT MELANOCORTIN 1 RECEPTOR SIGNALING WITH EMPHASIS ON PROTECTION AGAINST OXIDATIVE DAMAGE TO DNA
1
Universidad de Murcia / Instituto Murciano de Investigación Biosanitaria, El Palmar (Murcia), Spain |
PO-43 |
The role of MC1R in melanogenesis signaling: cAMP and beyond
1
Weill Cornell Medicine, New York, United States of America |
PO-44 |
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood samples.
1
MRGM - U1211, Bordeaux, France |
PO-45 |
Generating by CRISPR tools and phenotyping new mouse models of albinism with patient-specific mutations.
1
Centro Nacional de Biotecnología, Madrid, Spain |
PO-46 |
Melanin synthesis in the test tube: seeking of the simple tool to understand the mechanism of oculocutaneous albinism.
1
National Institutes of Health, Bethesda, United States of America |
PO-47 |
Prediction of postinflammatory hyperpigmentation after laser treatment from dermoscopic findings of solar lentigo
1
Ansan Hospital, Korea University, Ansan, Republic of Korea |
PO-48 |
Design of a new molecule proven to be safe and effective for topical depigmenting and antiaging methods
1
Mesoestetic Pharma Group, Viladecans, Spain |
PO-49 |
Integrated analysis using epidermis from solar lentigo lesions by whole genome bisulfite sequencing and RNA sequencing
1
MIRAI Technology Institute, Shiseido Co., Ltd., Yokohama, |
PO-50 |
EFFECT OF THE CULTURE CONDITIONS OF EPIDERMAL MELANOCYTES ON THEIR MORPHOLOGY AND FUNCTIONALITY
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
PO-51 |
CEMIP regulates skin fibroblast activation: implications in the melanoma microenvironment
1
University of the Basque Country (UPV/EHU), Sopela, Spain |
PO-52 |
Tyrosine mediates the phenotypic plasticity of melanoma by modulating oxidative stress both in vitro and in an animal model
1
Institut Jules Bordet-Ulb, Bruxelles, Belgium |
PO-53 |
Melanocytes in the corneoscleral limbus: much more than suppliers of melanin for limbal epithelial stem cells.
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
Poster sessions Axular room |
PO-54 |
Contribution of the Visible Light color domains in sun-induced pigmentation
1
L'Oreal Research and Innovation, Aulnay-sous-Bois, France |
PO-55 |
Risk-taking personality influences sun exposure habits: the role of CADM2
1
Universidade de São Paulo, São Paulo, Brazil |
PO-56 |
Chronic inflammation is evidenced in actinic lentigine from European and Asian volunteers
1
L'Oreal Research & Innovation, Aulnay sous Bois, France |
PO-57 |
Is Periorbital Melanoses a window for Metabolic Syndrome? A case series
1
DR. VASANTRAO PAWAR MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTRE, NASHIK, INDIA, NASHIK, India |
PO-58 |
Altered gut microbiome diversity aligns with disease activity in vitiligo
1
National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan |
PO-59 |
Relating disease severity to treatment efficacy by HSP70iQ435A for vitiligo
1
National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan |
PO-60 |
The comparison of 590nm light-emitting diodes and 1064nm Q-switched Nd:YAG laser as treatment for melasma
1
Fudan University Huashan Hospital, Shanghai, People's Republic of China |
PO-61 |
Lipid imaging mass spectrometry for the identificacion of lentigo maligna and primary melanoma
1
University of the Basque Country (UPV/EHU), Leioa, Spain |
PO-62 |
Uncovering the molecular mechanisms of crystal Formation in iridophores through cryo-EM and proteomics
1
Weizmann Institute of Science, Rehovot, Israel |
PO-63 |
Feasibility of High Resolution, Real-time Optical Coherence Tomography in the Evaluation of Vitiligo: A Prospective Longitudinal Follow-up Study
1
Chang Gung Memorial Hospital, Taipei, Taiwan, Republic of China |
PO-64 |
Novel synergistic combination of active ingredients for melasma topical therapy
1
Mesoestetic Pharma Group, Viladecans, Spain |
PO-65 |
Effectiveness of compound glycyrrhizin in combination with phototherapy in child vitiligo patients
1
Huashan Hospital, Fudan University, Shanghai, People's Republic of China |
PO-66 |
Cysteamine/isobionic-amide complex : A novel skin depigmenting combination for the treatment of skin hyperpigmentary disorders
1
Scientis SA, Geneve, |
PO-67 |
Targeting keratinocytes in vitiligo skin: an alternative strategy?
1
San Gallicano Dermatological Institute, IRCCS, Roma, Italy |
Room | Level |
Hall |
Level 0 |
Mitxelena |
Level 0 |
Chillida |
Level 1 |
Oteiza |
Level 1 |
Arriaga |
Level 2 |
Baroja |
Level 2 |
In this link you can see the different rooms.